Aethl Bio, Inc.

05/27/2026

What does robust chronic wound care actually look like?

Three shifts:
*Patient-centered, multi-disciplinary assessments.

*Bioactive dressings and pharmacological treatments that restore function, not just close the surface.

*Clinical regulations that redefine what counts as a healed wound.

These essential shifts are explored in our new white paper, "A Wound That Won't Heal." At Aethl, we believe that understanding these systemic changes is vital for advancing the future standard of care.

Read the full paper here: https://aethl.com/white-papers/wound-that-wont-heal/

05/20/2026

New from Aethl Bio: A Wound That Won't Heal.

Chronic wounds carry mortality rates comparable to cancer, cost healthcare systems tens of billions a year, and remain one of the most under-prioritized conditions in modern medicine.

A 9-page brief on the silent epidemic breaks it down further. Join us for the next six Wednesdays as we highlight some of the key takeaways from this discussion.

Read the full paper → https://aethl.com/white-papers/wound-that-wont-heal/

05/18/2026

One of the greatest challenges in treating chronic wounds is knowing if a protocol is actually working before weeks have passed.

A cutting edge study recently published in BioMedical Engineering OnLine outlines how machine learning can now predict the healing path of a diabetic foot ulcer using routine clinical data. With advancements like this doctors can better forecast if a wound will stall before the patient's next visit, allowing them to adjust the care plan accordingly.

Moving from a reactive approach to predictive, proactive care is exactly how the industry will improve patient outcomes.

By predicting these challenges early, clinicians can better support the body's natural ability to repair itself. At Aethl, we believe that innovative developments like these inspire the community to continue pushing forward.

Read about the new predictive model here: https://pmc.ncbi.nlm.nih.gov/articles/PMC12964848/

Diabetic foot ulcer management relies predominantly on reactive treatment adjustments based on current wound status. This study developed an accessible machine learning framework using routinely collected clinical metadata (no imaging required) to ...

05/06/2026

While we have seen incredible progress in cancer survival and cardiac care, chronic wounds remain a "silent epidemic" with a global impact. Non-healing wounds like diabetic foot ulcers and pressure ulcers carry a five-year mortality rate comparable to cancer, yet they remain one of the most underserved areas of medical innovation.

The current landscape is at a breaking point:
• 1 in 5 people with a diabetic foot ulcer will eventually require an amputation.
• In the U.S., pressure ulcers cost the healthcare system over $28B annually.
• 1 in 6 Medicare beneficiaries currently lives with a chronic wound.

As the global population ages, this challenge will only intensify. Demographic projections show the over-65 population doubling or even tripling in major regions by 2050-2060. The healthcare system requires a shift in how we approach these complex cases before the demographic curve exceeds current capacity.

Aethl Bio is tracking these shifts closely. We have released a new paper, A Wound That Won't Heal, designed for clinicians, investors, and operators to better understand the diagnostic gaps and the future of wound care.

You can read the full paper here: https://aethl.com/white-papers/wound-that-wont-heal/

04/22/2026

Aethl Bio, Inc. has announced it has entered a Memorandum of Understanding with The Pure Source, LLC, an FDA-registered, cGMP-certified contract manufacturer headquartered in Miami, Florida. The MOU establishes a preliminary framework for collaboration on the manufacturing of Aethl Bio's proprietary products, with the intent to negotiate a definitive long-term manufacturing agreement.

Read the full release: https://tinyurl.com/4bmnxryx

Preliminary agreement establishes framework for manufacturing collaboration as Aethl Bio advances toward commercialization.

04/19/2026

An interesting recent study in Frontiers in Bioengineering and Biotechnology (PMC12929217) has identified new ways that the body can achieve scarless repair. The research focuses on exosomes, which are tiny messengers that tell our cells how to rebuild tissue effectively without the formation of traditional scars.

Understanding these natural repair signals is changing the way we look at long-term skin health. Aethl Bio is following these advancements and is interested in the same ecosystem. We are focused on how to better support the body through precise science and infrastructure.

As we move toward a future of more intelligent recovery, the goal is to help the body repair itself as cleanly and efficiently as possible.

Read more about the research: https://pmc.ncbi.nlm.nih.gov/articles/PMC12929217/

The process of wound healing is intricate and, once disrupted, results in scar formation. Scar formation has negative physiological and psychological impacts on patients in addition to impeding the restoration of skin integrity and function. ...

04/14/2026

The International Journal of Lower Extremity Wounds recently published a review of the M.O.I.S.T. protocol. This framework updates the traditional approach to wound care by specifically including Oxygen balance as a core requirement for recovery.

This clinical shift supports a move toward more consistent healing environments. By standardizing these steps: Moisture, Oxygen, Infection, Supporting strategies, and Tissue management: the healthcare industry is refining how localized treatments are delivered.

Aethl Bio follows these updates to ensure alignment with current international standards for tissue restoration. As protocols become more standardized, the ability to maintain a pro-healing environment becomes more accessible outside of traditional clinical settings.

Read the research: https://journals.sagepub.com/doi/10.1177/15347346241245159

Chronic wounds remain a significant clinical challenge both for those affected and for healthcare systems. The treatment is often comprised and complex. All pat...

04/08/2026

The way we think about "healing" is undergoing a $49 billion transformation.

A new report from Persistence Market Research shows that the regenerative medicine industry is expected to more than triple in value over the next few years. This growth is driven by a simple truth: the world is moving away from just "masking" symptoms and moving toward treatments that actually repair the body.

At Aethl Bio, we are following these data-driven trends and are committed to delivering the solutions that make this level of recovery possible in your daily life. We believe that as medical science evolves, the tools we use to support our bodies must evolve too.

We are staying at the crest of this innovation wave to ensure the future of health is focused on true, deep restoration.

Building a stronger foundation for a life in motion.

Read the full study: https://www.persistencemarketresearch.com/market-research/regenerative-medicine-market.asp

Global regenerative medicine market to grow from US$ 49.4 Bn in 2026 to US$ 150.2 Bn by 2033, driven by cell therapy and biotech advances.

03/27/2026

A major scientific review published this year by Biomaterials Research shows that we are moving beyond basic treatments and into "Augmented Messengers." Scientists are now "supercharging" the tiny vesicles in our bodies so they can carry healing instructions exactly where they’re needed most—even crossing deep biological barriers to reach the brain and nervous system.

We stay focused on these breakthroughs because they change what’s possible for long-term health. When we can "program" how our bodies repair themselves, we move from just managing age to actively maintaining a high-performance body.

As the science of longevity evolves, the tools we use to stay active must become more precise. Better messengers mean a faster, more reliable return to a life in motion.

Heal Deeply. Live Fully.

Read more about the breakthrough: https://pmc.ncbi.nlm.nih.gov/articles/PMC12917129/

Exosomes are nanovesicles secreted by cells to exchange materials and information. Recent studies have revealed that these modified nanovesicles can be powerful tools for the diagnosis and treatment of diseases. However, few studies have reported on ...

03/20/2026

Healing shouldn't stop just because you left the doctor's office.

A recent study on oxygen therapy highlights a major shift in how we recover. While oxygen has always been a key to repairing tissue, the move is toward more flexible, portable options. Instead of visiting a clinic for a single session, new technology allows for "continuous" care that stays with you all day.

Aethl Bio is right in the middle of this movement. We believe that professional-grade recovery shouldn't be a destination you have to visit; it should be something you carry with you. We’re working to make sure the best tools for restoration are also the most mobile.

Because the best way to heal deeply is to keep living fully.

Read the research: https://journals.sagepub.com/doi/full/10.1177/15347346211053694

Natrox™ topical oxygen therapy (TOT) (Inotec AMD Ltd, Cambridgeshire, UK) employs a small battery-powered “oxygen generator” to concentrate atmospheric oxygen a...